Abstract
The noninvasive detection of apoptosis, or programmed cell death, is an important biomarker for the severity/progression of diseases and the efficacy of anticancer therapies. In the past decade a rapid expansion in the number of apoptosis imaging agents and techniques offers an increasingly wide selection of approaches for the assessment of apoptosis in vivo. The goal of this review is to provide a general account of existing and emerging apoptosis imaging techniques based on their modes of actions; and to critically discuss the major advantages and obstacles facing the field of apoptosis imaging. In conclusion, tremendous progress has been made in applying the concept of apoptosis imaging toward diagnostic needs. However, for imaging strategies involving exogenous agents, we must recognize the intrinsic distinction between probe density and target density, and appreciate the complexity of apoptosis imaging within the context of probe behaviors in the target tissue. For non-pharmaceutical imaging strategies, there is a continued drive to improve the specificity and applicability of these endogenous markers. Overall, what remains to be addressed, and is critical to clinical translation, is the noninvasive quantification, in addition to detection, of apoptosis in vivo.
Anti-Cancer Agents in Medicinal Chemistry
Title: In Vivo Apoptosis Imaging Agents and Strategies
Volume: 9 Issue: 9
Author(s): Ming Zhao
Affiliation:
Keywords: Apoptosis, imaging, probe
Abstract: The noninvasive detection of apoptosis, or programmed cell death, is an important biomarker for the severity/progression of diseases and the efficacy of anticancer therapies. In the past decade a rapid expansion in the number of apoptosis imaging agents and techniques offers an increasingly wide selection of approaches for the assessment of apoptosis in vivo. The goal of this review is to provide a general account of existing and emerging apoptosis imaging techniques based on their modes of actions; and to critically discuss the major advantages and obstacles facing the field of apoptosis imaging. In conclusion, tremendous progress has been made in applying the concept of apoptosis imaging toward diagnostic needs. However, for imaging strategies involving exogenous agents, we must recognize the intrinsic distinction between probe density and target density, and appreciate the complexity of apoptosis imaging within the context of probe behaviors in the target tissue. For non-pharmaceutical imaging strategies, there is a continued drive to improve the specificity and applicability of these endogenous markers. Overall, what remains to be addressed, and is critical to clinical translation, is the noninvasive quantification, in addition to detection, of apoptosis in vivo.
Export Options
About this article
Cite this article as:
Zhao Ming, In Vivo Apoptosis Imaging Agents and Strategies, Anti-Cancer Agents in Medicinal Chemistry 2009; 9 (9) . https://dx.doi.org/10.2174/187152009789377691
DOI https://dx.doi.org/10.2174/187152009789377691 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Importance of Novel Inflammatory Biomarkers in Renal Disease
Current Medicinal Chemistry Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies
Current Drug Abuse Reviews Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
Current Pharmaceutical Design Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Sida cordifolia, a Traditional Herb in Modern Perspective – A Review
Current Traditional Medicine Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
Current Vascular Pharmacology Nanofiber Scaffolds for Treatment of Spinal Cord Injury
Current Medicinal Chemistry Novel Insights into the Pervasive Role of M3 Muscarinic Receptor in Cardiac Diseases
Current Drug Targets The Role of Cnidaria in Drug Discovery. A Review on CNS Implications and New Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Intracellular Calcium Homeostasis and Kidney Disease
Current Medicinal Chemistry Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research
Current Alzheimer Research Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Current Opinion and Future Trends)
Current Pharmaceutical Design The Temporal and Spatial Distribution of Macrophage Subpopulations During Arteriogenesis
Current Vascular Pharmacology Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart
Current Cardiology Reviews Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells
Current Pharmaceutical Design Depression in Coronary Heart Disease Patients: Etiological and Screening Issues
Current Psychiatry Reviews Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Current Neuropharmacology Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
CNS & Neurological Disorders - Drug Targets